Cancer Therapy and Testing Market Insight, Size, Share, Growth, Up-To-Date Key Trends, Regional Outlook, and Forecast - 2030
Price : US$ 3,000 | Date : Jul 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 125 |
The latest update of “Global Urinary Tract Cancer Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Urinary Tract Cancer Market.
Overview of the Urinary Tract Cancer Market:
Urinary tract cancer is most common in young adults and is found in women older than 50 years. Many cases are multicentric and associated with concurrent bladder cancer. Twenty-four percent of patients diagnosed with upper tract cancer also had a tumor on the opposite side. A bladder tumor is more likely to have a high risk of transitional cell cancer, while cancer in the upper urinary tract is less likely to occur in the lower urinary tract. Despite this, a large proportion of patients with UC develop both types of upper tract tumors.
Rising prevalence of bladder cancer around the globe is a prime factor fueling the market growth of urinary tract cancer. The American Cancer Society’s estimates for bladder cancer in the United States for 2021 are: about 83,730 new cases of bladder cancer (about 64,280 in men and 19,450 in women) and about 17,200 deaths from bladder cancer (about 12,260 in men and 4,940 in women) Increasing focus of key players to improve distribution channel for bladder cancer drug is again fostering growth of the market. For instance, in May 2018, Ferring signs global agreement to commercialize novel gene therapy for bladder cancer patients who are unresponsive to Bacillus Calmette-Guérin (BCG) therapy.
North America is expected to witness significant growth over the forecast period owing to the increasing launch of new drugs for the treatment of urinary tract cancer. For instance, in April 2019, The U.S. Food and Drug Administration granted approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2.
Key Developments:
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Urinary Tract Cancer Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Urinary Tract Cancer Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Urinary Tract Cancer Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
The report covers the following Regions:
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
Why You Should Buy This Report:
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urinary Tract Cancer Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Urinary Tract Cancer Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Urinary Tract Cancer Market
1.6.1 How the Covid-19 is Affecting the Urinary Tract Cancer Market
1.6.1.1 Urinary Tract Cancer Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Urinary Tract Cancer Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Urinary Tract Cancer Market Perspective (2015-2028)
2.2 Urinary Tract Cancer Market Growth Trends by Regions
2.2.1 Urinary Tract Cancer Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Urinary Tract Cancer Market Historic Market Share by Regions (2015-2021)
2.2.3 Urinary Tract Cancer Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Urinary Tract Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Urinary Tract Cancer Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Urinary Tract Cancer Market Players by Market Size
3.1.1 Global Top Urinary Tract Cancer Market Players by Revenue (2015-2021)
3.1.2 Global Urinary Tract Cancer Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Urinary Tract Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urinary Tract Cancer Market Concentration Ratio
3.2.1 Global Urinary Tract Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Urinary Tract Cancer Market Revenue in 2019
3.3 Urinary Tract Cancer Market Key Players Head office and Area Served
3.4 Key Players Urinary Tract Cancer Market Product Solution and Service
3.5 Date of entering into Urinary Tract Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Urinary Tract Cancer Market Historic Market Size by Type (2015-2021)
4.2 Global Urinary Tract Cancer Market Forecasted Market Size by Type (2021-2028)
5 Urinary Tract Cancer Market Breakdown Data by Application (2015-2028)
5.1 Global Urinary Tract Cancer Market Size by Application (2015-2021)
5.2 Global Urinary Tract Cancer Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Urinary Tract Cancer Market Size (2015-2021)
6.2 Urinary Tract Cancer Market Key Players in North America (2019-2021)
6.3 North America Urinary Tract Cancer Market Size by Type (2015-2021)
6.4 North America Urinary Tract Cancer Market Size by Application (2015-2021)
7 Europe
7.1 Europe Urinary Tract Cancer Market Size (2015-2021)
7.2 Urinary Tract Cancer Market Key Players in Europe (2019-2021)
7.3 Europe Urinary Tract Cancer Market Size by Type (2015-2021)
7.4 Europe Urinary Tract Cancer Market Size by Application (2015-2021)
8 China
8.1 China Urinary Tract Cancer Market Size (2015-2021)
8.2 Urinary Tract Cancer Market Key Players in China (2019-2021)
8.3 China Urinary Tract Cancer Market Size by Type (2015-2021)
8.4 China Urinary Tract Cancer Market Size by Application (2015-2021)
9 Japan
9.1 Japan Urinary Tract Cancer Market Size (2015-2021)
9.2 Urinary Tract Cancer Market Key Players in Japan (2019-2021)
9.3 Japan Urinary Tract Cancer Market Size by Type (2015-2021)
9.4 Japan Urinary Tract Cancer Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Urinary Tract Cancer Market Size (2015-2021)
10.2 Urinary Tract Cancer Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Urinary Tract Cancer Market Size by Type (2015-2021)
10.4 Southeast Asia Urinary Tract Cancer Market Size by Application (2015-2021)
11 India
11.1 India Urinary Tract Cancer Market Size (2015-2021)
11.2 Urinary Tract Cancer Market Key Players in India (2019-2021)
11.3 India Urinary Tract Cancer Market Size by Type (2015-2021)
11.4 India Urinary Tract Cancer Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Urinary Tract Cancer Market Size (2015-2021)
12.2 Urinary Tract Cancer Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Urinary Tract Cancer Market Size by Type (2015-2021)
12.4 Central & South America Urinary Tract Cancer Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Urinary Tract Cancer Market Introduction
13.4 Urinary Tract Cancer Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Urinary Tract Cancer Market Key Market Segments
Table 2. Key Players Covered: Ranking by Urinary Tract Cancer Market Revenue
Table 3. Ranking of Global Top Urinary Tract Cancer Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urinary Tract Cancer Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Urinary Tract Cancer Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Urinary Tract Cancer Market Players to Combat Covid-19 Impact
Table 10. Global Urinary Tract Cancer Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Urinary Tract Cancer Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Urinary Tract Cancer Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Urinary Tract Cancer Market Share by Regions (2015-2021)
Table 14. Global Urinary Tract Cancer Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Urinary Tract Cancer Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Urinary Tract Cancer Market Growth Strategy
Table 20. Main Points Interviewed from Key Urinary Tract Cancer Market Players
Table 21. Global Urinary Tract Cancer Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Urinary Tract Cancer Market Share by Players (2015-2021)
Table 23. Global Top Urinary Tract Cancer Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Cancer Market as of 2019)
Table 24. Global Urinary Tract Cancer Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Urinary Tract Cancer Market Product Solution and Service
Table 27. Date of entering into Urinary Tract Cancer Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 30. Global Urinary Tract Cancer Market Size Share by Type (2015-2021)
Table 31. Global Urinary Tract Cancer Market Revenue Market Share by Type (2021-2028)
Table 31. Global Urinary Tract Cancer Market Size Share by Application (2015-2021)
Table 33. Global Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 34. Global Urinary Tract Cancer Market Size Share by Application (2021-2028)
Table 35. North America Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 37. North America Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 38. North America Urinary Tract Cancer Market Share by Type (2015-2021)
Table 39. North America Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 40. North America Urinary Tract Cancer Market Share by Application (2015-2021)
Table 41. Europe Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 43. Europe Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Urinary Tract Cancer Market Share by Type (2015-2021)
Table 45. Europe Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Urinary Tract Cancer Market Share by Application (2015-2021)
Table 47. China Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 49. China Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 50. China Urinary Tract Cancer Market Share by Type (2015-2021)
Table 51. China Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 52. China Urinary Tract Cancer Market Share by Application (2015-2021)
Table 53. Japan Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 55. Japan Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Urinary Tract Cancer Market Share by Type (2015-2021)
Table 57. Japan Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Urinary Tract Cancer Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 61. Southeast Asia Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Urinary Tract Cancer Market Share by Type (2015-2021)
Table 63. Southeast Asia Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Urinary Tract Cancer Market Share by Application (2015-2021)
Table 65. India Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 67. India Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 68. India Urinary Tract Cancer Market Share by Type (2015-2021)
Table 69. India Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 70. India Urinary Tract Cancer Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Urinary Tract Cancer Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Urinary Tract Cancer Market Share (2019-2021)
Table 73. Central & South America Urinary Tract Cancer Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Urinary Tract Cancer Market Share by Type (2015-2021)
Table 75. Central & South America Urinary Tract Cancer Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Urinary Tract Cancer Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Urinary Tract Cancer Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Urinary Tract Cancer Market Share by Type: 2021 VS 2028
Figure 2. Global Urinary Tract Cancer Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Urinary Tract Cancer Market Report Years Considered
Figure 8. Global Urinary Tract Cancer Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Urinary Tract Cancer Market Share by Regions: 2021 VS 2028
Figure 10. Global Urinary Tract Cancer Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Urinary Tract Cancer Market Share by Players in 2019
Figure 13. Global Top Urinary Tract Cancer Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Urinary Tract Cancer Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Urinary Tract Cancer Market Revenue in 2019
Figure 15. North America Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Urinary Tract Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Price : US$ 3,000 | Date : Jul 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 125 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 120 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 150 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Medical Devices | Pages : 123 |
Price : US$ 3,000 | Date : Jun 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 160 |
In search of customized market research solution? We are here to help you. Contact us.